|1.||Kazanietz, Marcelo G: 3 articles (09/2009 - 05/2003)|
|2.||Gomez, Daniel E: 2 articles (01/2005 - 05/2003)|
|3.||Menna, Pablo Lorenzano: 2 articles (01/2005 - 05/2003)|
|4.||Alonso, Daniel F: 2 articles (01/2005 - 05/2003)|
|5.||Sosa, Maria Soledad: 1 article (09/2009)|
|6.||Choi, Sung-Hee: 1 article (09/2009)|
|7.||Blumberg, Peter M: 1 article (09/2009)|
|8.||Lewin, Nancy E: 1 article (09/2009)|
|9.||Bruinsma, Stephen P: 1 article (10/2007)|
|10.||Baranski, Thomas J: 1 article (10/2007)|
09/01/2009 - "Recent studies established that the Rac-GAP beta2-chimaerin plays important roles in development, neuritogenesis, and cancer progression. "
10/15/2007 - "Emerging evidence implicates beta2-chimaerin in tumor progression. "
09/01/2007 - "beta2-Chimaerin negatively controls many Rac-dependent pathophysiological events including tumor development. "
05/01/2003 - "Our results indicate that beta2-chimaerin impairs key steps in the metastatic cascade and provide evidence for a rational modulation of the Rac signaling pathway in cancer treatment."
10/15/2007 - "Beta2-chimaerin in cancer signaling: connecting cell adhesion and MAP kinase activation."
01/01/2005 - "Role of beta2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix components."
05/01/2003 - "Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain."
05/01/2003 - "To explore the potential role of beta2-chimaerin in invasion and metastasis, we generated stable transfectants for its catalytic domain (the beta-GAP domain) in F3II murine mammary carcinoma cells. "
01/01/2005 - "In this work, we analysed cell morphology, actin cytoskeleton reorganisation and metalloprotease (MMP) secretion in response to matrix proteins in mouse mammary carcinoma cells transfected with the beta2-chimaerin GAP domain. "
|4.||Neoplasm Metastasis (Metastasis)
|1.||Proteins (Proteins, Gene)